Worldwide Vascular Endothelial Growth Factor Inhibitor Industry to 2030 - Players Include Regeneron Pharmaceuticals, Astrazeneca & Novartis Among Others - ResearchAndMarkets.com
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- The top opportunities in the vascular endothelial growth factor (VEGF) inhibitor market segmented by drugs type will arise in the tecentriq segment, which will gain $4,596.9 million of global annual sales by 2025.
- The vascular endothelial growth factor (VEGF) inhibitor market size will gain the most in the USA at $7,015.6 million.